Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5X05
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,631
Award facts
- Contract value 100% obligated
- $34,630.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,630.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pens on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a GLP-1 receptor agonist used in diabetes and weight management treatment, reflecting the Department of Defense's need for pharmaceutical supplies to support military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031. This single-award IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen, as a major pharmaceutical distributor and critical federal vendor, regularly fulfills delivery orders under this vehicle to supply essential medications to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5X05?
SPE2DR26F5X05 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F5X05 worth?
The government has obligated $34,631 on SPE2DR26F5X05.
Is contract SPE2DR26F5X05 an order under another contract?
Yes. SPE2DR26F5X05 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5X05 competed?
The extent of competition for SPE2DR26F5X05 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award